These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22920357)

  • 21. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
    Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anterior Prostate Cancer: Diagnostic Performance of T2-Weighted MRI and an Apparent Diffusion Coefficient Map.
    Shinmoto H; Tamura C; Soga S; Okamura T; Horiguchi A; Asano T; Kaji T
    AJR Am J Roentgenol; 2015 Aug; 205(2):W185-92. PubMed ID: 26204306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
    Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
    Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
    Song I; Kim CK; Park BK; Park W
    AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
    Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.
    Wang X; Qian Y; Liu B; Cao L; Fan Y; Zhang JJ; Yu Y
    Clin Radiol; 2014 Nov; 69(11):1165-70. PubMed ID: 25182363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy.
    Park BK; Lee HM; Kim CK; Choi HY; Park JW
    Invest Radiol; 2008 Nov; 43(11):789-93. PubMed ID: 18923258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
    Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
    Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.
    Maas MC; Fütterer JJ; Scheenen TW
    Invest Radiol; 2013 Nov; 48(11):779-86. PubMed ID: 23907102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.
    Zhang K; Shen Y; Zhang X; Ma L; Wang H; An N; Guo A; Ye H
    PLoS One; 2016; 11(3):e0151176. PubMed ID: 26963936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
    Kim CK; Park BK; Han JJ; Kang TW; Lee HM
    J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
    Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy.
    Jeong IG; Kim JK; Cho KS; You D; Song C; Hong JH; Ahn H; Kim CS
    J Urol; 2010 Nov; 184(5):1963-9. PubMed ID: 20851437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis.
    Li B; Cai W; Lv D; Guo X; Zhang J; Wang X; Fang J
    J Magn Reson Imaging; 2013 Jan; 37(1):194-200. PubMed ID: 23002033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values.
    Bozkurt M; Doganay S; Kantarci M; Yalcin A; Eren S; Atamanalp SS; Yuce I; Yildirgan MI
    Eur J Radiol; 2011 Nov; 80(2):224-8. PubMed ID: 20598823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.